The STEP-1 Study app is for data capture for the GI Dynamics Clinical Trial. The study is a randomized, multi-center, pivotal efficacy and safety study, evaluating the EndoBarrier® System for Glycemic Improvement in patients with inadequately controlled type 2 diabetes and obesity.
This app is specifically intended for study participants in the STEP-1 study.